Mechanistic experiments further suggested that ChREBP overexpression, by inducing SCD1 expression, favorably modifies lipid composition in hepatocytes and thus dissociates hepatic steatosis from insulin resistance [40]. This evidence concerns the gene SCD and fatty liver disease.